838 results on '"Sheiban Imad"'
Search Results
202. Pressure Ulcer: An Unreported Complication of the Safeguard® Hemostasis Device. No Need to Crack Under Pressure
203. Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients
204. When are two stents needed? Which technique is the best? How to perform?
205. Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4314-patient registry
206. Single- versus multiple-vessel stenting for patients with ST-elevation myocardial infarction: results from a 30,886-patient meta-analysis
207. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial
208. Sex-related differences in patients undergoing percutaneous unprotected left main stenting
209. Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis
210. Current management of unprotected left main coronary artery disease: Run-in survey of the RITMO (Registro Italiano sul Trattamento del tronco coMune non protettO) study
211. Response to Letter Regarding Article, “Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations: The CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study”
212. Systematic reviews and meta-analyses “For Dummies”
213. Impact of multivessel stenting on top of percutaneous revascularization for unprotected left main disease in the drug-eluting stent era: insights from the Turin registry
214. Long-term effect of chronic oral anticoagulation: focus on coronary artery disease
215. Temporal Pattern of Ischemic Events in Relation to Dual Antiplatelet Therapy in Patients With Unprotected Left Main Coronary Artery Stenosis Undergoing Percutaneous Coronary Intervention
216. Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations
217. Intramural left atrial hematoma: A complication of primary coronary angioplasty inferior myocardial infarction
218. Homing of annexin-labeled stem cells to apoptotic cells
219. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction
220. Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions
221. Early and long‐term results of percutaneous coronary intervention for unprotected left main trifurcation disease
222. Impact of Bifurcation Technique on 2-Year Clinical Outcomes in 773 Patients With Distal Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stents
223. Two-Year Clinical Outcome With Drug-Eluting Stents Versus Bare-Metal Stents in a Real-World Registry of Unprotected Left Main Coronary Artery Stenosis from the Italian Society of Invasive Cardiology
224. Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease
225. Appraising the pathophysiologic impact of coronary collaterals as measured by fractional flow reserve on symptoms and signs of myocardial ischemia
226. Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: A dangerous duo?
227. Abstract 4270: Comprehensive Meta-Analysis on Oral Anticoagulants for the Secondary Prevention of Coronary Artery Disease Including more than 50,000 Patients
228. Effect of a novel drug-eluted balloon coated with Genistein before stent implantation in porcine coronary arteries
229. A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial
230. Safety of drug-coated stents
231. Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year
232. Reply
233. A prospective multicentre observational study on the management of unprotected left main coronary artery disease: rationale and design of the Registro Italiano sul Trattamento del tronco comune non protetto study
234. Sirolimus-eluting stent implantation for bare-metal in-stent restenosis: is there any evidence for a late catch-up phenomenon?
235. Percutaneous coronary intervention on left main coronary artery trifurcation
236. ST-Segment Elevation Myocardial Infarction Due to Early and Late Stent Thrombosis
237. Longest Available Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease
238. Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention
239. Impact of impedance threshold devices on cardiopulmonary resuscitation: A systematic review and meta-analysis of randomized controlled studies
240. Last nail in the coffin of late lumen loss?
241. Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)
242. Very very late thrombosis of a sirolimus-eluting stent: does suboptimal stent expansion take its toll even after three years?
243. Letter by Bollati et al Regarding Article, “Off-Pump Versus On-Pump Coronary Artery Bypass Graft Surgery: Differences in Short-Term Outcomes and in Long-Term Mortality and Need for Subsequent Revascularization”
244. Challenges of Meta-Analyses Pooling Non-Randomized Controlled Studies
245. Survival and Cardiac Remodeling Benefits in Patients Undergoing Late Percutaneous Coronary Intervention of the Infarct-Related Artery
246. Letter Regarding Article by Solomon et al, “Cardiac Angiography in REnally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease”
247. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease
248. Retrograde septal approach for a challenging chronic total occlusion of the right coronary artery
249. Fenoldopam Reduces the Need for Renal Replacement Therapy and In-Hospital Death in Cardiovascular Surgery: A Meta-Analysis
250. Overcoming “resistance” to aspirin and clopidogrel with tirofiban: fact or fiction?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.